KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Non-Current Debt (2016 - 2026)

AbbVie has reported Non-Current Debt over the past 14 years, most recently at $58.9 billion for Q4 2025.

  • Quarterly Non-Current Debt fell 2.32% to $58.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $58.9 billion through Dec 2025, down 2.32% year-over-year, with the annual reading at $58.9 billion for FY2025, 2.32% down from the prior year.
  • Non-Current Debt was $58.9 billion for Q4 2025 at AbbVie, down from $63.0 billion in the prior quarter.
  • Over five years, Non-Current Debt peaked at $74.2 billion in Q2 2021 and troughed at $52.2 billion in Q4 2023.
  • The 5-year median for Non-Current Debt is $60.7 billion (2022), against an average of $62.2 billion.
  • Year-over-year, Non-Current Debt grew 17.22% in 2021 and then fell 18.43% in 2022.
  • A 5-year view of Non-Current Debt shows it stood at $64.2 billion in 2021, then decreased by 7.87% to $59.1 billion in 2022, then decreased by 11.74% to $52.2 billion in 2023, then grew by 15.61% to $60.3 billion in 2024, then fell by 2.32% to $58.9 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Non-Current Debt are $58.9 billion (Q4 2025), $63.0 billion (Q3 2025), and $63.0 billion (Q2 2025).